Grifols, S.A Operating Income 2012-2019 | GRFS

Grifols, S.A annual/quarterly operating income history and growth rate from 2012 to 2019. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Grifols, S.A operating income for the quarter ending September 30, 2019 was $M, a 100% decline year-over-year.
  • Grifols, S.A operating income for the twelve months ending September 30, 2019 was $0.982B, a 6.81% decline year-over-year.
  • Grifols, S.A annual operating income for 2019 was $1.267B, a 7.93% increase from 2018.
  • Grifols, S.A annual operating income for 2018 was $1.174B, a 3.53% increase from 2017.
  • Grifols, S.A annual operating income for 2017 was $1.134B, a 9.09% increase from 2016.
Grifols, S.A Annual Operating Income
(Millions of US $)
2019 $1,267
2018 $1,174
2017 $1,134
2016 $1,040
2015 $1,077
2014 $1,140
2013 $978
2012 $849
2011 $450
Grifols, S.A Quarterly Operating Income
(Millions of US $)
2019-09-30
2019-06-30 $356
2018-06-30 $312
2017-06-30 $314
2017-03-31 $269
2016-12-31 $267
2016-09-30 $267
2016-06-30 $250
2016-03-31 $255
2015-12-31 $276
2015-09-30 $275
2015-06-30 $259
2015-03-31 $264
2014-12-31 $171
2014-09-30 $284
2014-06-30 $237
2014-03-31 $324
2013-12-31 $209
2013-09-30 $247
2013-06-30 $266
2013-03-31 $248
2012-12-31 $188
2012-09-30 $215
2012-06-30 $216
2012-03-31 $213
2011-12-31 $796
2011-09-30 $807
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $13.187B $5.711B
Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $54.432B 31.49
Takeda Pharmaceutical (TAK) Japan $45.999B 8.06
Astellas Pharma (ALPMY) Japan $27.558B 13.76
Eisai (ESALY) Japan $19.334B 36.02
UCB SA (UCBJF) Belgium $15.687B 0.00
Merck (MKGAF) Germany $12.536B 16.44
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Neurocrine Biosciences (NBIX) United States $7.917B 219.95
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.874B 0.00
Catalent (CTLT) United States $7.164B 29.48
Ionis Pharmaceuticals (IONS) United States $6.754B 20.47
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.361B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $5.544B 6.76
Orion OYJ (ORINY) Finland $5.269B 23.61
STADA ARZNEIMI (STDAF) Germany $4.685B 0.00
Forty Seven (FTSV) United States $4.597B 0.00
IPSEN SA ADR (IPSEY) France $4.543B 0.00
United Therapeutics (UTHR) United States $4.070B 0.00
Evotec AG (EVTCY) Germany $3.428B 55.29
Hypermarcas (HYPMY) Brazil $3.424B 10.41
Nektar Therapeutics (NKTR) United States $2.994B 0.00
FibroGen (FGEN) United States $2.866B 0.00
PTC Therapeutics (PTCT) United States $2.666B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.655B 49.28
Taro Pharmaceutical Industries (TARO) Israel $2.418B 9.78
ChemoCentryx (CCXI) United States $2.402B 0.00
Xencor (XNCR) United States $1.649B 67.35
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.620B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.561B 18.98
Theravance Biopharma (TBPH) Cayman Islands $1.439B 0.00
Sage Therapeutics (SAGE) United States $1.347B 0.00
USANA Health Sciences (USNA) United States $1.344B 14.11
Corcept Therapeutics (CORT) United States $1.335B 14.94
Pacira Pharmaceuticals (PCRX) United States $1.295B 35.40
Karyopharm Therapeutics (KPTI) United States $1.168B 0.00
Heron Therapeutics (HRTX) United States $1.056B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.010B 31.30
Zogenix (ZGNX) United States $1.010B 0.00
Akebia Therapeutics (AKBA) United States $0.874B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.859B 11.96
Esperion Therapeutics (ESPR) United States $0.846B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.781B 0.00
Endo (ENDP) Ireland $0.721B 1.33
ImmunoGen (IMGN) United States $0.596B 0.00
Tilray (TLRY) Canada $0.576B 0.00
Translate Bio (TBIO) United States $0.572B 0.00
Aerie Pharmaceuticals (AERI) United States $0.565B 0.00
Molecular Templates (MTEM) United States $0.561B 0.00
Collegium Pharmaceutical (COLL) United States $0.553B 0.00
Radius Health (RDUS) United States $0.550B 0.00
Portola Pharmaceuticals (PTLA) United States $0.504B 0.00
Indivior (INVVY) United States $0.397B 2.36
Siga Technologies (SIGA) United States $0.393B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.386B 15.84
Innate Pharma SA (IPHYF) France $0.385B 0.00
Ardelyx (ARDX) United States $0.378B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.365B 12.17
Corbus Pharmaceuticals Holdings (CRBP) United States $0.354B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.324B 0.00
Organogenesis Holdings (ORGO) United States $0.312B 0.00
Trillium Therapeutics (TRIL) Canada $0.301B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.301B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.299B 0.00
Calithera Biosciences (CALA) United States $0.286B 0.00
Lannett Co Inc (LCI) United States $0.285B 4.58
Harpoon Therapeutics (HARP) United States $0.277B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.263B 0.00
DURECT (DRRX) United States $0.260B 0.00
Flexion Therapeutics (FLXN) United States $0.256B 0.00
Ocular Therapeutix (OCUL) United States $0.251B 0.00
TherapeuticsMD (TXMD) United States $0.250B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.246B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.243B 0.00
Concert Pharmaceuticals (CNCE) United States $0.232B 0.00
Rafael Holdings (RFL) United States $0.186B 0.00
CASI Pharmaceuticals (CASI) United States $0.185B 0.00
Recro Pharma (REPH) United States $0.166B 0.00
OptiNose (OPTN) United States $0.164B 0.00
PROFOUND MEDICL (PROF) Canada $0.157B 0.00
MEI Pharma (MEIP) United States $0.155B 0.00
Jounce Therapeutics (JNCE) United States $0.145B 2.61
Nature's Sunshine Products (NATR) United States $0.140B 17.58
La Jolla Pharmaceutical (LJPC) United States $0.140B 0.00
Taiwan Liposome (TLC) Taiwan $0.137B 0.00
KalVista Pharmaceuticals (KALV) United States $0.135B 0.00
VAXART, INC (VXRT) United States $0.120B 0.00
Redhill Biopharma (RDHL) Israel $0.104B 0.00
CannTrust Holdings (CTST) Canada $0.090B 0.00
IMV INC (IMV) Canada $0.086B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.084B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.081B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.081B 0.00
Champions Oncology (CSBR) United States $0.080B 0.00
SCYNEXIS (SCYX) United States $0.079B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.074B 0.00
CTI BioPharma (CTIC) United States $0.070B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.068B 0.00
Biomerica (BMRA) United States $0.065B 0.00
CV Sciences (CVSI) United States $0.064B 0.00
Xeris Pharmaceuticals (XERS) United States $0.064B 0.00
Aquestive Therapeutics (AQST) United States $0.062B 0.00
Otonomy (OTIC) United States $0.060B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.056B 17.62
ALLERGY THERAPT (AGYTF) United Kingdom $0.055B 0.00
Nivalis Therapeutics (ALPN) United States $0.054B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.052B 0.00
Onconova Therapeutics (ONTX) United States $0.048B 0.00
Infinity Pharmaceuticals (INFI) United States $0.047B 0.00
Aclaris Therapeutics (ACRS) United States $0.046B 0.00
PharmAthene (ALT) United States $0.045B 0.00
GTx (ONCT) United States $0.044B 0.00
Natural Alternatives (NAII) United States $0.043B 19.47
MediWound (MDWD) Israel $0.040B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.040B 133.57
Sundial Growers (SNDL) Canada $0.040B 0.00
Iterum Therapeutics (ITRM) Ireland $0.036B 0.00
Neos Therapeutics (NEOS) United States $0.036B 0.00
Forward Pharma (FWP) Denmark $0.035B 0.00
PolarityTE (PTE) United States $0.035B 0.00
ElectroCore (ECOR) United States $0.031B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.031B 0.00
Heat Biologics (HTBX) United States $0.029B 0.00
Jaguar Animal Health (JAGX) United States $0.026B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.024B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.023B 0.00
ProPhase Labs (PRPH) United States $0.022B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.021B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.021B 0.00
Cardiome Pharma (CORV) Canada $0.021B 0.00
Lipocine (LPCN) United States $0.020B 0.00
Mannatechorporated (MTEX) United States $0.018B 5.78
Bio-Path Holdings (BPTH) United States $0.018B 0.00
Novan (NOVN) United States $0.018B 0.00
Cyanotech (CYAN) United States $0.013B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.012B 0.00
Shineco (TYHT) China $0.012B 0.00
China SXT Pharmaceuticals (SXTC) China $0.011B 0.00
Vical (BBI) United States $0.011B 0.00
KemPharm (KMPH) United States $0.010B 0.00
Regulus Therapeutics (RGLS) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.007B 0.00
Midatech Pharma (MTP) United Kingdom $0.006B 0.00
HANCOCK JAFFE (HJLI) United States $0.006B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.006B 0.00
RXi Pharmaceuticals (PHIO) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Flex Pharma (SLRX) United States $0.003B 0.00